living donor laparoscopic hepatectomy
Conditions
Interventions
Experimental group:Ultrasound-guided transverse abdominal muscle block
Control group:local anesthetic wound infiltration
Sponsors
Beijing Friendship Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 65 years, ASA I~II; 2. Patients scheduled to undergo laparoscopic living donor hepatectomy with inflow occlusion (Pringle maneuver).
Exclusion criteria
Exclusion criteria: 1. History of severe cardiovascular disease; 2. puncture site infection; 3. allergy to local anesthetics 4. chronic pain and long-term use of analgesic drugs 5. drug or alcohol abuse; 6. those who refuse to participate in observation. 7. those who have been turned on intraoperatively; 8. Intraoperative hemorrhage; 9. Serious adverse events such as local anesthetic poisoning; 10. Post-operative unplanned transfer to ICU with tracheal tube; 11. Persons who undergo a second operation within 48 hours after surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the cumulative opioid consumption within 24 hours post-operatively; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS pain scores at rest and during movement;Quality of postoperative recovery;PCIA pump use;exhaust time, ambulation time, PACU time, and hospital stay;sleep in-terruptions as a result of pain;use of rescue analgesics;time to first opioid use;ropivacaine plasma concentration; | — |
Countries
China
Contacts
Public ContactCui Lingli
Beijing Friendship Hospital, Capital Medical University
Outcome results
None listed